Edwards Lifesciences Liabilities 2024

Edwards Lifesciences Aktienanalyse

What does Edwards Lifesciences do?

Edwards Lifesciences Corp is a globally operating company in the field of medical technology, specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. The company was founded in California in 1958 and is now one of the leading companies in the field of modern heart valve technology. The history of Edwards Lifesciences begins with its founding by Miles "Lowell" Edwards and his longtime employee Dr. Albert Starr. They recognized the need for a less invasive and more effective alternative to heart valves than the existing surgical methods. They received their first patent in 1960 and performed their first successful heart valve operation on a sheep in the same year. The first surgeries on humans took place in 1962. Edwards Lifesciences quickly expanded in the US and internationally. The business model of Edwards Lifesciences focuses on three business areas: "Transcatheter Heart Valve Systems," "Surgical Heart Valve Therapy," and "Critical Care." Each area is focused on a specific range of products and is supported by its own team of professionals. The "Transcatheter Heart Valve Systems" area has become the most important division of Edwards Lifesciences. This novel technology enables the implantation of an artificial heart valve system through minimally invasive surgical methods, without the need for an open procedure. The system consists of a foldable heart valve made of animal tissue or artificial material, which is inserted into the damaged heart through a catheter. This method is applicable to a wide range of patients and has become an important tool in the treatment of heart diseases. The "Surgical Heart Valve Therapy" business area includes implantable mechanical and biological heart valves for open surgical procedures. Edwards Lifesciences develops innovative products to meet the needs of surgical patients and doctors. The third business area, "Critical Care," offers instruments and technologies for the critical medical care of patients in intensive care units and emergency departments. The company manufactures collagen matrix products for wound care, catheter monitoring systems, and patient monitoring devices to detect potential life-threatening complications early. Over the years, Edwards Lifesciences has introduced numerous innovative products to the market that are used in medical practice. The Edwards SAPIEN Transcatheter Heart Valve System was approved in Europe in 2011 and in the US in 2012 and has since improved the lives of tens of thousands of patients. With new technologies such as the Edwards SAPIEN 3 and SAPIEN 3 Ultra platforms, the company is constantly striving to increase the effectiveness and safety of heart disease treatment. Edwards Lifesciences is headquartered in Irvine, California, and is a multinational company with locations in North America, Europe, India, and Asia. The company currently employs approximately 14,000 people worldwide and is an important pillar of the medical community. Answer: Edwards Lifesciences Corp is a global medical technology company specializing in the development, production, and distribution of products for the treatment of heart diseases and critical illnesses. It is a leader in modern heart valve technology. Edwards Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Edwards Lifesciences's Liabilities

Edwards Lifesciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Edwards Lifesciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Edwards Lifesciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Edwards Lifesciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Edwards Lifesciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Edwards Lifesciences Stock

What is the level of liabilities of Edwards Lifesciences this year?

Edwards Lifesciences has a debt balance of 2.71 B USD this year.

What were the liabilities of Edwards Lifesciences compared to the previous year?

The liabilities of Edwards Lifesciences have increased by 9.15% increased compared to the previous year.

What are the consequences of high debt for investors of Edwards Lifesciences?

High liabilities can pose a risk for investors of Edwards Lifesciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Edwards Lifesciences?

Low liabilities mean that Edwards Lifesciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Edwards Lifesciences affect the company?

An increase in liabilities of Edwards Lifesciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Edwards Lifesciences affect the company?

A decrease in the liabilities of Edwards Lifesciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Edwards Lifesciences?

Some factors that can influence the liabilities of Edwards Lifesciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Edwards Lifesciences so important for investors?

The liabilities of Edwards Lifesciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Edwards Lifesciences take to modify the liabilities?

To change its liabilities, Edwards Lifesciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Edwards Lifesciences pay?

Over the past 12 months, Edwards Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Edwards Lifesciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Edwards Lifesciences?

The current dividend yield of Edwards Lifesciences is .

When does Edwards Lifesciences pay dividends?

Edwards Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Edwards Lifesciences?

Edwards Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Edwards Lifesciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Edwards Lifesciences located?

Edwards Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Edwards Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Edwards Lifesciences from 4/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/19/2024.

When did Edwards Lifesciences pay the last dividend?

The last dividend was paid out on 4/19/2024.

What was the dividend of Edwards Lifesciences in the year 2023?

In the year 2023, Edwards Lifesciences distributed 0 USD as dividends.

In which currency does Edwards Lifesciences pay out the dividend?

The dividends of Edwards Lifesciences are distributed in USD.